- MACROCYCLIC KINASE INHIBITORS
-
Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
- -
-
Page/Page column 115
(2012/06/16)
-
- Fused Bicyclic Kinase Inhibitors
-
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
- -
-
Page/Page column 69
(2011/11/30)
-